HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Short report: lack of prediction of amodiaquine efficacy in treating Plasmodium falciparum malaria by in vitro tests.

Abstract
Amodiaquine (AQ) is currently a major candidate for new antimalarial combinations, although in vivo and in vitro tests have been rarely simultaneously investigated. The efficacy of AQ was assessed at the dose of 30 mg/kg in treating Plasmodium falciparum malaria attacks in 74 children from southeast Gabon, and the in vitro activity of monodesethylamodiaquine (MdAQ), the main metabolite of AQ, was measured against P. falciparum parasites isolated from these children. Treatment failures were observed in 40.5% of the children, while 5.4% of the isolates showed in vitro resistance to MdAQ. No relationship was observed between in vivo and in vitro susceptibility. The in vitro activities of MdAQ and chloroquine were correlated. The reasons for such disparities between in vivo and in vitro AQ activities are discussed and the issue of the validity of in vitro tests to measure AQ efficacy is raised.
AuthorsAgnes Aubouy, Justice Mayombo, Annick Keundjian, Mohamed Bakary, Jacques Le Bras, Philippe Deloron
JournalThe American journal of tropical medicine and hygiene (Am J Trop Med Hyg) Vol. 71 Issue 3 Pg. 294-6 (Sep 2004) ISSN: 0002-9637 [Print] United States
PMID15381809 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antimalarials
  • Amodiaquine
  • desethylamodiaquine
Topics
  • Amodiaquine (analogs & derivatives, metabolism, therapeutic use)
  • Antimalarials (therapeutic use)
  • Child
  • Child, Preschool
  • Drug Resistance (genetics)
  • Gabon
  • Humans
  • In Vitro Techniques
  • Malaria, Falciparum (drug therapy, genetics)
  • Parasitic Sensitivity Tests (methods)
  • Predictive Value of Tests
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: